Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	MPOS	POSD
	SPEN(49.7%)	exon11,c.6915_6917del,p.S2306del	0.497	0.159	20|20	7|0	0.54762	19|23	1	16259647	16259650	TAGC	T	germline,panel_of_normals	SPEN	NM_015001.3	11	c.6915_6917del	p.Ser2306del	disruptive_inframe_deletion				54	0.0
-	ARID1A(20.9%)	exon3,c.1392dup,p.Q465fs	0.209	0.006033	928|253	253|0	0.21484	1429|391	1	27057682	27057682	C	CA	PASS	ARID1A	NM_006015.6	3	c.1392dup	p.Gln465fs	frameshift_variant				40	0.0
1	NRAS(0.1%)	exon4,c.437C>T,p.A146V	0.001255	0.001524	6680|8	2436|3	0.00101	19761|20	1	115252203	115252203	G	A	clustered_events,haplotype,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.437C>T	p.Ala146Val	missense_variant				47	0.0
1	NRAS(0.1%)	exon4,c.436G>T,p.A146S	0.0006004	0.001823	6689|6	2434|6	0.00141	19822|28	1	115252204	115252204	C	A	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>T	p.Ala146Ser	missense_variant				39	0.0
1	NRAS(0.0%)	exon4,c.436G>C,p.A146P	0.0002278	0.0006108	6689|5	2434|1	0.00111	19822|22	1	115252204	115252204	C	G	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>C	p.Ala146Pro	missense_variant				50	0.0
1	NRAS(0.1%)	exon4,c.436G>A,p.A146T	0.000733	0.00104	6689|4	2434|2	0.00045	19822|9	1	115252204	115252204	C	T	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>A	p.Ala146Thr	missense_variant				56	0.0
1	NRAS(0.0%)	exon3,c.182A>T,p.Q61L	0.0004182	0.000937	3713|3	1580|1	0.00103	10720|11	1	115256529	115256530	T	A	base_qual,clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	3	c.182A>T	p.Gln61Leu	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Melanoma|Adrenocortical_carcinoma|B-cell_chronic_lymphocytic_leukemia|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_brain|Adenocarcinoma_of_stomach|Neoplasm_of_the_thyroid_gland|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Ovarian_Serous_Cystadenocarcinoma|Glioblastoma|Malignant_neoplasm_of_body_of_uterus	36	0.0
1	NRAS(0.1%)	exon3,c.181C>A,p.Q61K	0.001108	0.0009051	3709|6	1571|0	0.00121	10772|13	1	115256530	115256530	G	T	clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	3	c.181C>A	p.Gln61Lys	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1),Uncertain_significance(1)	Vascular_Tumors_Including_Pyogenic_Granuloma|Hepatocellular_carcinoma|Acute_myeloid_leukemia|Melanoma|Adrenocortical_carcinoma|Neuroblastoma|B-cell_chronic_lymphocytic_leukemia|Large_congenital_melanocytic_nevus|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_brain|Adenocarcinoma_of_stomach|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Ovarian_Serous_Cystadenocarcinoma|Neurocutaneous_melanocytosis|Glioblastoma|Rasopathy|Malignant_neoplasm_of_body_of_uterus|Ras_Inhibitor_response|not_provided	34	0.0
1	NRAS(0.0%)	exon2,c.38G>T,p.G13V	0.0003427	0.0005209	8569|4	2927|1	0.00093	22544|21	1	115258744	115258746	C	A	clustered_events,normal_artifact,orientation,weak_evidence	NRAS	NM_002524.5	2	c.38G>T	p.Gly13Val	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Neoplasm|Melanoma|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Malignant_melanoma_of_skin|Non-Hodgkin_lymphoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Myelodysplastic_syndrome	40	0.0
1	NRAS(0.0%)	exon2,c.37G>T,p.G13C	0.0004991	0.0005242	8572|10	2929|1	0.00207	22668|47	1	115258745	115258746	C	A	base_qual,clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.37G>T	p.Gly13Cys	missense_variant	Pathogenic		Melanoma	32	0.0
1	NRAS(0.1%)	exon2,c.34G>T,p.G12C	0.0006525	0.0005286	8513|8	2889|1	0.00140	22809|32	1	115258748	115258748	C	A	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.34G>T	p.Gly12Cys	missense_variant	Pathogenic		Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Malignant_melanoma_of_skin|Non-small_cell_lung_carcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Myelodysplastic_syndrome|Malignant_neoplasm_of_body_of_uterus|not_provided	38	0.0
	LCE1F(10.0%)	exon2,c.55A>C,p.K19Q	0.1	0.111	43|4	9|0	0.09412	77|8	1	152748902	152748902	A	C	orientation	LCE1F	NM_178354.3	2	c.55A>C	p.Lys19Gln	missense_variant				43	0.0
	PIK3C2B(2.8%)	exon18,c.2552G>A,p.S851N	0.028	0.049	193|5	27|0	0.02155	227|5	1	204415210	204415210	C	T	PASS	PIK3C2B	NM_002646.4	18	c.2552G>A	p.Ser851Asn	missense_variant				62	0.0
-	MSH6(4.6%)	exon5,c.3261del,p.F1088fs	0.046	0.04	3022|179	732|38	0.04105	5794|248	2	48030639	48030640	AC	A	normal_artifact,panel_of_normals,slippage	MSH6	NM_000179.3	5	c.3261del	p.Phe1088fs	frameshift_variant	Pathogenic		Lynch-like_syndrome|Endometrial_carcinoma|Carcinoma_of_colon|Lynch_syndrome|Hereditary_cancer-predisposing_syndrome|Mismatch_repair_cancer_syndrome_3|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided	39	0.0
1	IDH1(0.2%)	exon4,c.394C>T,p.R132C	0.002331	0.001397	3585|8	1042|1	0.00406	6867|28	2	209113113	209113113	G	A	clustered_events,orientation,weak_evidence	IDH1	NM_005896.4	4	c.394C>T	p.Arg132Cys	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Astrocytoma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome|not_provided	22	0.0
	ERBB4(2.1%)	exon21,c.2586T>G,p.F862L	0.021	0.039	339|8	34|0	0.01636	421|7	2	212295727	212295727	A	C	PASS	ERBB4	NM_005235.3	21	c.2586T>G	p.Phe862Leu	missense_variant				23	0.0
	ANO10(3.3%)	exon2,c.132del,p.D45fs	0.033	0.058	1035|41	175|11	0.03368	1951|68	3	43647212	43647213	CT	C	multiallelic,normal_artifact,panel_of_normals,slippage	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Spinocerebellar_ataxia	57	0.0
	ANO10(1.3%)	exon2,c.132dup,p.D45fs	0.013	0.024	1035|15	175|5	0.01564	1951|31	3	43647212	43647213	CT	CTT	multiallelic,normal_artifact,panel_of_normals,slippage	ANO10	NM_018075.5	2	c.132dup	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Spinocerebellar_ataxia,_autosomal_recessive_10|Autosomal_recessive_cerebellar_ataxia|not_provided	49	0.0
	SLC35G2(2.6%)	exon2,c.192del,p.R66fs	0.026	0.038	917|33	141|6	0.03258	1455|49	3	136573485	136573486	GA	G	multiallelic,panel_of_normals,slippage	SLC35G2	NM_001097599.2	2	c.192del	p.Arg66fs	frameshift_variant				35	0.0
	SLC35G2(3.2%)	exon2,c.192dup,p.G65fs	0.032	0.01	917|36	141|1	0.04024	1455|61	3	136573485	136573486	GA	GAA	multiallelic,panel_of_normals,slippage	SLC35G2	NM_001097599.2	2	c.192dup	p.Gly65fs	frameshift_variant				35	0.0
	ATR(6.3%)	exon10,c.2320del,p.I774fs	0.063	0.045	4723|392	1234|81	0.05712	11902|721	3	142274739	142274740	AT	A	multiallelic,normal_artifact,panel_of_normals,slippage	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		Endometrial_neoplasm|not_provided	44	0.0
	ATR(2.4%)	exon10,c.2320dup,p.I774fs	0.024	0.027	4723|168	1234|49	0.03651	11902|451	3	142274739	142274740	AT	ATT	multiallelic,normal_artifact,panel_of_normals,slippage	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic		not_provided	45	0.0
1	PIK3CA(0.1%)	exon10,c.1624G>A,p.E542K	0.001006	0.003358	4561|4	469|0	0.00058	12032|7	3	178936082	178936082	G	A	clustered_events,orientation,strand_bias,weak_evidence	PIK3CA	NM_006218.4	10	c.1624G>A	p.Glu542Lys	missense_variant	Pathogenic		CEREBRAL_CAVERNOUS_MALFORMATIONS_4,_SOMATIC|Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Carcinoma_of_esophagus|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Adenocarcinoma_of_prostate|Squamous_cell_carcinoma_of_the_head_and_neck|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Capillary_malformation_of_the_lower_lip,_lymphatic_malformation_of_face_and_neck,_asymmetry_of_face_and_limbs,_and_partial/generalized_overgrowth|Brain_malformation|Glioblastoma|Lip_and_oral_cavity_carcinoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus|not_provided	31	0.0
1	PIK3CA(0.1%)	exon10,c.1634A>C,p.E545A	0.0006826	0.003315	4444|6	456|0	0.00145	11696|17	3	178936092	178936092	A	C	base_qual,clustered_events,orientation,weak_evidence	PIK3CA	NM_006218.4	10	c.1634A>C	p.Glu545Ala	missense_variant	Pathogenic		Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Carcinoma_of_gallbladder|Adenocarcinoma_of_prostate|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus	48	0.0
1	PIK3CA(0.1%)	exon21,c.3140A>G,p.H1047R	0.0008993	0.001141	6431|4	1272|0	0.00091	20800|19	3	178952085	178952085	A	G	clustered_events,orientation	PIK3CA	NM_006218.4	21	c.3140A>G	p.His1047Arg	missense_variant	Pathogenic		CEREBRAL_CAVERNOUS_MALFORMATIONS_4,_SOMATIC|Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|MACRODACTYLY,_SOMATIC|Segmental_undergrowth_associated_with_lymphatic_malformation|Segmental_undergrowth_associated_with_mainly_venous_malformation_with_capillary_component|Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Neoplasm|Medulloblastoma|Adrenocortical_carcinoma|Congenital_macrodactylia|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_stomach|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Rosette-forming_glioneuronal_tumor|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Seborrheic_keratosis|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Breast_adenocarcinoma|Adenocarcinoma_of_prostate|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Capillary_malformation_of_the_lower_lip,_lymphatic_malformation_of_face_and_neck,_asymmetry_of_face_and_limbs,_and_partial/generalized_overgrowth|Brain_malformation|Familial_cancer_of_breast|Glioblastoma|Lip_and_oral_cavity_carcinoma|Malignant_neoplasm_of_body_of_uterus|OVARIAN_CANCER,_EPITHELIAL,_SOMATIC|PIK3CA_related_overgrowth_spectrum|not_provided	37	0.0
1	PIK3CA(0.4%)	exon21,c.3140A>T,p.H1047L	0.004075	0.001147	6431|28	1272|1	0.00555	20800|116	3	178952085	178952085	A	T	clustered_events,orientation	PIK3CA	NM_006218.4	21	c.3140A>T	p.His1047Leu	missense_variant	Pathogenic		CEREBRAL_CAVERNOUS_MALFORMATIONS_4,_SOMATIC|Stroke|Hepatocellular_carcinoma|Hemihypertrophy|Medulloblastoma|Adrenocortical_carcinoma|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Macrodactyly_of_toe|Neoplasm_of_the_large_intestine|Breast_adenocarcinoma|Adenocarcinoma_of_prostate|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Cowden_syndrome_1|Squamous_cell_carcinoma_of_the_head_and_neck|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Capillary_malformation_of_the_lower_lip,_lymphatic_malformation_of_face_and_neck,_asymmetry_of_face_and_limbs,_and_partial/generalized_overgrowth|Glioblastoma|Malignant_neoplasm_of_body_of_uterus|PIK3CA_related_overgrowth_spectrum	41	0.0
	MUC4(30.1%)	exon2,c.11580_11583del,p.S3861fs	0.301	0.158	19|6	5|0	0.00000	29|0	3	195506867	195506871	GGCTA	G	germline,panel_of_normals	MUC4	NM_018406.7	2	c.11580_11583del	p.Ser3861fs	frameshift_variant				7	0.0
	MUC4(22.9%)	exon2,c.3207C>T,p.H1069=	0.229	0.12	26|5	9|0	0.12500	105|15	3	195515244	195515244	G	A	haplotype,panel_of_normals	MUC4	NM_018406.7	2	c.3207C>T	p.His1069=	synonymous_variant				15	0.0
	MUC4(16.5%)	exon2,c.3194C>A,p.A1065E	0.165	0.12	27|3	8|0	0.17886	101|22	3	195515257	195515257	G	T	contamination,haplotype,panel_of_normals	MUC4	NM_018406.7	2	c.3194C>A	p.Ala1065Glu	missense_variant				11	0.0
1	PDGFRA(0.1%)	exon18,c.2525A>T,p.D842V	0.0007854	0.001078	4501|3	1472|1	0.00218	9632|21	4	55152093	55152093	A	T	orientation,strand_bias,weak_evidence	PDGFRA	NM_006206.6	18	c.2525A>T	p.Asp842Val	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(2),Uncertain_significance(1)	Gastrointestinal_stromal_tumor|not_provided	36	0.0
1	KIT(0.1%)	exon11,c.1669T>A,p.W557R	0.000541	0.001189	5590|4	1257|3	0.00287	14260|41	4	55593603	55593603	T	A	base_qual,clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1669T>A	p.Trp557Arg	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stromal_tumor	54	0.0
	KIT(0.0%)	exon11,c.1669T>G,p.W557G	0.0002603	0.001186	5590|4	1257|0	0.00126	14260|18	4	55593603	55593603	T	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1669T>G	p.Trp557Gly	missense_variant	Likely_pathogenic		Gastrointestinal_stromal_tumor	10	0.0
1	KIT(0.0%)	exon11,c.1676T>A,p.V559D	0.0002638	0.001192	5521|3	1237|0	0.00396	14076|56	4	55593610	55593610	T	A	clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1676T>A	p.Val559Asp	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stromal_tumor	62	0.0
1	KIT(0.1%)	exon11,c.1676T>C,p.V559A	0.0008603	0.001192	5521|5	1237|0	0.00064	14076|9	4	55593610	55593610	T	C	clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1676T>C	p.Val559Ala	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Thymoma|Gastrointestinal_stromal_tumor|Cutaneous_mastocytosis|Gastrointestinal_stromal_tumor,_familial	11	0.0
1	KIT(0.0%)	exon11,c.1676T>G,p.V559G	0.0003516	0.001206	5521|14	1237|4	0.00460	14076|65	4	55593610	55593610	T	G	clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1676T>G	p.Val559Gly	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stromal_tumor	28	0.0
	INPP4B(7.3%)	exon15,c.1111G>A,p.A371T	0.073	0.167	54|4	6|0	0.06349	59|4	4	143114310	143114310	C	T	PASS	INPP4B	NM_001101669.3	15	c.1111G>A	p.Ala371Thr	missense_variant				32	0.0
	MSH3(1.8%)	exon7,c.1148dup,p.N385fs	0.018	0.014	2201|57	931|12	0.02121	4615|100	5	79970914	79970914	C	CA	normal_artifact,panel_of_normals,slippage	MSH3	NM_002439.5	7	c.1148dup	p.Asn385fs	frameshift_variant	Pathogenic		not_provided	43	0.0
-	APC(44.8%)	exon16,c.4348C>T,p.R1450*	0.448	0.016	264|210	77|0	0.46884	375|331	5	112175639	112175639	C	T	PASS	APC	NM_000038.6	16	c.4348C>T	p.Arg1450*	stop_gained	Pathogenic		Neoplasm_of_the_large_intestine|Hereditary_cancer-predisposing_syndrome|Familial_multiple_polyposis_syndrome|Familial_adenomatous_polyposis_1|not_provided	36	0.0
	RAD50(4.9%)	exon13,c.2165del,p.K722fs	0.049	0.053	8055|505	2641|174	0.04786	33363|1677	5	131931451	131931453	TAA	TA	multiallelic,normal_artifact,panel_of_normals,slippage	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome	42	0.0
	RAD50(0.2%)	exon13,c.2164_2165del,p.K722fs	0.002365	0.0009655	8055|19	2641|1	0.00168	33363|56	5	131931451	131931453	TAA	T	multiallelic,normal_artifact,panel_of_normals,slippage	RAD50	NM_005732.4	13	c.2164_2165del	p.Lys722fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome	39	0.0
	RAD50(1.5%)	exon13,c.2165dup,p.E723fs	0.015	0.014	8055|167	2641|64	0.02667	33363|914	5	131931451	131931453	TAA	TAAA	multiallelic,normal_artifact,panel_of_normals,slippage	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided	41	0.0
	HLA-DQA1(10.9%)	exon2,c.90C>T,p.H30=	0.109	0.143	57|6	7|0	0.14286	66|11	6	32609094	32609094	C	T	contamination,panel_of_normals	HLA-DQA1	NM_002122.5	2	c.90C>T	p.His30=	synonymous_variant				50	0.0
1	EGFR(0.0%)	exon18,c.2126A>T,p.E709V	0.0003897	0.001697	3865|4	907|2	0.00118	7618|9	7	55241678	55241680	A	T	base_qual,clustered_events,weak_evidence	EGFR	NM_005228.5	18	c.2126A>T	p.Glu709Val	missense_variant	Uncertain_significance		not_specified	12	0.0
1	EGFR(0.1%)	exon18,c.2153T>A,p.L718Q	0.001379	0.002228	2864|4	651|1	0.00180	5538|10	7	55241705	55241705	T	A	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	18	c.2153T>A	p.Leu718Gln	missense_variant				17	0.0
1	EGFR(0.0%)	exon19,c.2240_2251del,p.L747_T751>S	0.0001673	0.0007005	9318|1	2289|0	0.00000	19266|0	7	55242469	55242487	TTAAGAGAAGCAACATCTC	TCATCTC	base_qual,clustered_events,contamination,weak_evidence	EGFR	NM_005228.5	19	c.2240_2251del	p.Leu747_Thr751delinsSer	disruptive_inframe_deletion				1	0.0
1	EGFR(0.1%)	exon20,c.2374C>T,p.L792F	0.001328	0.003183	2295|3	476|0	0.00079	3807|3	7	55249076	55249076	C	T	clustered_events,contamination,orientation,weak_evidence	EGFR	NM_005228.5	20	c.2374C>T	p.Leu792Phe	missense_variant				36	0.0
1	EGFR(0.2%)	exon20,c.2387G>A,p.G796D	0.001983	0.006445	2248|6	454|1	0.00160	3737|6	7	55249089	55249089	G	A	clustered_events,contamination,normal_artifact,orientation,weak_evidence	EGFR	NM_005228.5	20	c.2387G>A	p.Gly796Asp	missense_variant				50	0.0
1	EGFR(0.1%)	exon20,c.2389T>G,p.C797G	0.0008366	0.003363	2209|3	445|0	0.00301	3648|11	7	55249091	55249091	T	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2389T>G	p.Cys797Gly	missense_variant				22	0.0
1	EGFR(0.1%)	exon21,c.2572C>A,p.L858M	0.001264	0.002299	3426|4	680|0	0.00140	5719|8	7	55259514	55259514	C	A	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	21	c.2572C>A	p.Leu858Met	missense_variant	Uncertain_significance		Non-small_cell_lung_carcinoma|not_specified	49	0.0
1	EGFR(0.1%)	exon21,c.2573T>G,p.L858R	0.0008093	0.002323	3398|8	670|2	0.00334	5665|19	7	55259515	55259515	T	G	base_qual,clustered_events,contamination,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	21	c.2573T>G	p.Leu858Arg	missense_variant	drug_response		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Lung_carcinoma|Adenocarcinoma_of_lung,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Erlotinib_response|Gefitinib_response|Tyrosine_kinase_inhibitor_response|gefitinib_response_-_Efficacy	27	0.0
1	MET(0.1%)	exon14,c.2888-1G>A	0.0005122	0.001316	7643|5	1076|0	0.00048	26933|13	7	116411902	116411902	G	A	weak_evidence	MET	NM_000245.4	13	c.2888-1G>A		splice_acceptor_variant&intron_variant				31	0.0
1	MET(0.0%)	exon14,c.3008A>G,p.Y1003C	0.0002832	0.001256	7736|3	1198|0	0.00035	33823|12	7	116412023	116412023	A	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3008A>G	p.Tyr1003Cys	missense_variant				43	0.0
1	MET(0.1%)	exon14,c.3008A>T,p.Y1003F	0.0005807	0.001264	7736|11	1198|1	0.00330	33823|112	7	116412023	116412023	A	T	base_qual,clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3008A>T	p.Tyr1003Phe	missense_variant				41	0.0
1	MET(0.0%)	exon14,c.3028G>T,p.D1010Y	0.0001953	0.001225	7800|7	1244|3	0.00418	34340|144	7	116412043	116412043	G	T	base_qual,clustered_events,orientation,weak_evidence	MET	NM_000245.4	14	c.3028G>T	p.Asp1010Tyr	missense_variant&splice_region_variant				30	0.0
1	MET(0.1%)	exon14,c.3028+1G>A	0.0009069	0.001218	7789|8	1246|0	0.00087	34325|30	7	116412044	116412044	G	A	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028+1G>A		splice_donor_variant&intron_variant	not_provided		not_provided	25	0.0
1	MET(0.0%)	exon14,c.3028+2T>A	0.0004715	0.00123	7692|5	1237|1	0.00258	34011|88	7	116412045	116412045	T	A	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028+2T>A		splice_donor_variant&intron_variant				51	0.0
	MET(33.6%)	exon17,c.3497G>A,p.R1166Q	0.336	0.035	364|181	76|1	0.34507	465|245	7	116418986	116418986	G	A	PASS	MET	NM_000245.4	17	c.3497G>A	p.Arg1166Gln	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_benign(1),Uncertain_significance(2)	Renal_cell_carcinoma|Hereditary_cancer-predisposing_syndrome|not_provided	35	0.0
	BRAF(0.1%)	exon15,c.1802A>T,p.K601I	0.0005484	0.002562	5618|6	617|0	0.00395	17672|70	7	140453133	140453133	T	A	base_qual,clustered_events,orientation,weak_evidence	BRAF	NM_004333.6	15	c.1802A>T	p.Lys601Ile	missense_variant	Likely_pathogenic		Cardio-facio-cutaneous_syndrome|Rasopathy|not_provided	25	0.0
0	BRAF(0.0%)	exon15,c.1799T>G,p.V600G	0.0002747	0.002577	5545|3	613|0	0.00098	17406|17	7	140453136	140453137	A	C	base_qual,clustered_events,orientation,weak_evidence	BRAF	NM_004333.6	15	c.1799T>G	p.Val600Gly	missense_variant	Pathogenic		Melanoma|Cardio-facio-cutaneous_syndrome|Rasopathy|not_provided	41	0.0
1	BRAF(0.1%)	exon15,c.1799T>A,p.V600E	0.0005341	0.002576	5545|6	613|0	0.00406	17406|71	7	140453136	140453137	A	T	base_qual,clustered_events,orientation,weak_evidence	BRAF	NM_004333.6	15	c.1799T>A	p.Val600Glu	missense_variant	Pathogenic,_drug_response,_other		Cystic_epithelial_invagination_containing_papillae_lined_by_columnar_epithelium|Trametinib-Dabrafenib_Response|Vemurafenib-Cobimetinib_Response|Nephroblastoma|Cerebral_arteriovenous_malformation|Neoplasm|Melanoma|Papillary_thyroid_carcinoma|Multiple_myeloma|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_brain|Colonic_neoplasm|Neoplasm_of_ovary|Gastrointestinal_stromal_tumor|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Malignant_neoplastic_disease|Lung_carcinoma|Colorectal_cancer|Squamous_cell_carcinoma_of_the_head_and_neck|Cardio-facio-cutaneous_syndrome|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Germ_cell_tumor,_nonseminomatous|Astrocytoma,_low-grade,_somatic|not_provided	61	0.0
	BRAF(0.1%)	exon15,c.1796C>T,p.T599I	0.0007602	0.005163	5492|3	598|2	0.00063	17336|11	7	140453139	140453139	G	A	clustered_events,haplotype,orientation,strand_bias,weak_evidence	BRAF	NM_004333.6	15	c.1796C>T	p.Thr599Ile	missense_variant	Pathogenic		Neoplasm|Melanoma|Cardiofaciocutaneous_syndrome_1|Noonan_syndrome|Rasopathy|not_provided	24	0.0
-	KMT2C(1.8%)	exon38,c.8390dup,p.E2798fs	0.018	0.021	5914|151	1755|53	0.02819	15581|452	7	151874147	151874148	CT	CTT	multiallelic,normal_artifact,panel_of_normals,slippage	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided	41	0.0
	KMT2C(12.2%)	exon16,c.2763A>G,p.L921=	0.122	0.125	40|4	9|0	0.07843	47|4	7	151932908	151932908	T	C	contamination,panel_of_normals	KMT2C	NM_170606.3	16	c.2763A>G	p.Leu921=	synonymous_variant				39	0.0
	RP1L1(1.4%)	exon4,c.4020_4021del,p.E1340fs	0.014	0.023	1137|13	288|5	0.00000	1489|0	8	10467586	10467588	GTT	G	clustered_events,contamination,multiallelic,normal_artifact,panel_of_normals	RP1L1	NM_178857.6	4	c.4020_4021del	p.Glu1340fs	frameshift_variant	Pathogenic		Retinitis_pigmentosa_88	18	0.0
	KCNB2(2.1%)	exon2,c.435dup,p.E146fs	0.021	0.006117	897|22	211|0	0.01459	1418|21	8	73480396	73480396	C	CA	panel_of_normals,slippage	KCNB2	NM_004770.3	2	c.435dup	p.Glu146fs	frameshift_variant				35	0.0
	TSC1(7.0%)	exon23,c.3127_3129del,p.S1043del	0.07	0.037	175|13	29|0	0.06800	233|17	9	135771987	135771990	CGCT	C	panel_of_normals,slippage	TSC1	NM_000368.5	23	c.3127_3129del	p.Ser1043del	conservative_inframe_deletion	Benign		Tuberous_sclerosis_1|Tuberous_sclerosis_syndrome	29	0.0
1	RET(0.0%)	exon16,c.2753T>C,p.M918T	0.0002175	0.000419	14522|3	3807|0	0.00014	55281|8	10	43617416	43617416	T	C	orientation,strand_bias,weak_evidence	RET	NM_020975.6	16	c.2753T>C	p.Met918Thr	missense_variant	Pathogenic/Likely_pathogenic		Gingival_overgrowth|Hypertelorism|Hypothyroidism|Joint_hypermobility|Short_stature|Tetralogy_of_Fallot|Constipation|Pheochromocytoma|Medullary_thyroid_carcinoma|Thick_vermilion_border|Neoplasm_of_the_thyroid_gland|Multiple_endocrine_neoplasia,_type_1|Hirschsprung_disease_1|Familial_medullary_thyroid_carcinoma|Multiple_endocrine_neoplasia,_type_2b|Multiple_endocrine_neoplasia,_type_2a|Multiple_endocrine_neoplasia,_type_4|Multiple_endocrine_neoplasia,_type_2|Inborn_genetic_diseases|Thyroid_carcinoma,_sporadic_medullary|not_specified|not_provided	51	0.0
	IFITM3(5.3%)	exon1,c.124A>T,p.T42S	0.053	0.104	74|4	10|0	0.06000	94|6	11	320690	320690	T	A	panel_of_normals	IFITM3	NM_021034.3	1	c.124A>T	p.Thr42Ser	missense_variant				52	0.0
	MUC6(8.5%)	exon31,c.4908T>C,p.H1636=	0.085	0.05	158|20	25|0	0.35233	250|136	11	1017893	1017893	A	G	clustered_events,panel_of_normals	MUC6	NM_005961.3	31	c.4908T>C	p.His1636=	synonymous_variant				9	0.0
	MUC6(3.1%)	exon31,c.4866_4872delinsATCAGTC,p.L1623S	0.031	0.032	331|10	43|0	0.07843	376|32	11	1017929	1017935	CACCAAA	GACTGAT	clustered_events,panel_of_normals	MUC6	NM_005961.3	31	c.4866_4872delinsATCAGTC	p.Leu1623Ser	missense_variant				19	0.0
	MUC6(2.4%)	exon31,c.4866T>C,p.S1622=	0.024	0.033	305|6	40|0	0.13771	407|65	11	1017935	1017935	A	G	clustered_events,contamination,orientation,panel_of_normals	MUC6	NM_005961.3	31	c.4866T>C	p.Ser1622=	synonymous_variant				57	0.0
	MUC6(2.0%)	exon31,c.4846G>A,p.V1616I	0.02	0.03	378|6	45|0	0.05973	551|35	11	1017955	1017955	C	T	clustered_events,contamination,orientation,panel_of_normals	MUC6	NM_005961.3	31	c.4846G>A	p.Val1616Ile	missense_variant				54	0.0
	MUC6(2.8%)	exon31,c.4845C>T,p.H1615=	0.028	0.029	380|11	46|0	0.06133	551|36	11	1017956	1017960	G	A	clustered_events,contamination,multiallelic,panel_of_normals	MUC6	NM_005961.3	31	c.4845C>T	p.His1615=	synonymous_variant				45	0.0
	MUC6(5.5%)	exon31,c.4837C>A,p.P1613T	0.055	0.043	193|11	29|0	0.05573	610|36	11	1017964	1017964	G	T	clustered_events,contamination,panel_of_normals	MUC6	NM_005961.3	31	c.4837C>A	p.Pro1613Thr	missense_variant				48	0.0
	MUC6(2.0%)	exon31,c.4800T>G,p.T1600=	0.02	0.029	374|7	44|0	0.05500	567|33	11	1018001	1018001	A	C	clustered_events,contamination,haplotype,panel_of_normals	MUC6	NM_005961.3	31	c.4800T>G	p.Thr1600=	synonymous_variant				25	0.0
	MUC6(2.1%)	exon31,c.4786T>A,p.F1596I	0.021	0.028	341|7	50|0	0.05825	485|30	11	1018015	1018015	A	T	clustered_events,contamination,haplotype,panel_of_normals	MUC6	NM_005961.3	31	c.4786T>A	p.Phe1596Ile	missense_variant				11	0.0
	ESRRA(8.3%)	exon7,c.1055G>C,p.R352P	0.083	0.067	124|7	21|0	0.06875	149|11	11	64083221	64083221	G	C	clustered_events,contamination	ESRRA	NM_004451.5	7	c.1055G>C	p.Arg352Pro	missense_variant				23	0.0
	ESRRA(11.0%)	exon7,c.1086T>C,p.Y362=	0.11	0.084	102|9	16|0	0.10145	124|14	11	64083252	64083252	T	C	clustered_events,panel_of_normals	ESRRA	NM_004451.5	7	c.1086T>C	p.Tyr362=	synonymous_variant				42	0.0
	ESRRA(12.5%)	exon7,c.1103_1132delinsACCCCGGTGGGGGTGCTGAGCAGCTGC,p.G368_A378>DPGGGAEQLP	0.125	0.091	89|11	14|0	0.12800	109|16	11	64083269	64083298	GCCCCGGAGGGGGTGCTGAGCGGCGGCGGG	ACCCCGGTGGGGGTGCTGAGCAGCTGC	clustered_events,haplotype,orientation,panel_of_normals	ESRRA	NM_004451.5	7	c.1103_1132delinsACCCCGGTGGGGGTGCTGAGCAGCTGC	p.Gly368_Ala378delinsAspProGlyGlyGlyAlaGluGlnLeuPro	missense_variant&disruptive_inframe_deletion				48	0.0
	ESRRA(20.5%)	exon7,c.1152_1154delinsACC,p.L385P	0.205	0.125	36|14	8|0	0.31746	43|20	11	64083318	64083320	GCT	ACC	clustered_events,haplotype,orientation,panel_of_normals	ESRRA	NM_004451.5	7	c.1152_1154delinsACC	p.Leu385Pro	missense_variant				40	0.0
	ESRRA(21.6%)	exon7,c.1162_1165delinsTTCT,p.L388_R389>FC	0.216	0.125	34|14	7|0	0.37931	36|22	11	64083328	64083331	CTCC	TTCT	clustered_events,haplotype,panel_of_normals	ESRRA	NM_004451.5	7	c.1162_1165delinsTTCT	p.Leu388_Arg389delinsPheCys	missense_variant				44	0.0
	CD3G(3.3%)	exon3,c.213del,p.K71fs	0.033	0.039	1483|57	291|12	0.03017	2572|80	11	118220582	118220583	TA	T	multiallelic,normal_artifact,panel_of_normals,slippage	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1),Uncertain_significance(1)	Immunodeficiency_17	43	0.0
	CD3G(1.7%)	exon3,c.213dup,p.W72fs	0.017	0.019	1483|37	291|10	0.02094	2572|55	11	118220582	118220583	TA	TAA	multiallelic,normal_artifact,panel_of_normals,slippage	CD3G	NM_000073.3	3	c.213dup	p.Trp72fs	frameshift_variant	Pathogenic		Immunodeficiency_17	36	0.0
1	KRAS(0.1%)	exon4,c.437C>T,p.A146V	0.0007745	0.001424	5319|4	1101|0	0.00054	20367|11	12	25378561	25378562	G	A	orientation,weak_evidence	KRAS	NM_033360.4	4	c.437C>T	p.Ala146Val	missense_variant	Pathogenic		OCULOECTODERMAL_SYNDROME,_SOMATIC|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine	58	0.0
	KRAS(0.1%)	exon3,c.181C>G,p.Q61E	0.0006144	0.001122	5165|3	1436|0	0.00095	16888|16	12	25380277	25380277	G	C	clustered_events,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	3	c.181C>G	p.Gln61Glu	missense_variant	Likely_pathogenic		Neoplasm_of_the_large_intestine	48	0.0
1	KRAS(0.1%)	exon3,c.181C>A,p.Q61K	0.0006123	0.001122	5165|3	1436|1	0.00171	16888|29	12	25380277	25380277	G	T	clustered_events,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	3	c.181C>A	p.Gln61Lys	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine	28	0.0
1	KRAS(0.1%)	exon3,c.175G>A,p.A59T	0.0009072	0.001158	4946|4	1378|0	0.00088	15929|14	12	25380283	25380283	C	T	clustered_events,strand_bias,weak_evidence	KRAS	NM_033360.4	3	c.175G>A	p.Ala59Thr	missense_variant	Pathogenic/Likely_pathogenic		Neoplasm_of_the_large_intestine|Bladder_cancer,_transitional_cell,_somatic	59	0.0
1	KRAS(0.1%)	exon2,c.38G>T,p.G13V	0.0006651	0.001577	6729|5	2296|4	0.00302	13879|42	12	25398281	25398284	C	A	clustered_events,normal_artifact,weak_evidence	KRAS	NM_033360.4	2	c.38G>T	p.Gly13Val	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine|not_provided	56	0.0
1	KRAS(32.8%)	exon2,c.35G>A,p.G12D	0.328	0.001976	4499|2170	2291|4	0.32396	14071|6743	12	25398284	25398285	C	T	clustered_events	KRAS	NM_033360.4	2	c.35G>A	p.Gly12Asp	missense_variant	Pathogenic		Vascular_Tumors_Including_Pyogenic_Granuloma|Acute_myeloid_leukemia|Cerebral_arteriovenous_malformation|Neoplasm_of_stomach|Nevus_sebaceous|Epidermal_nevus|Epidermal_nevus_syndrome|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Lung_carcinoma|Carcinoma_of_pancreas|RAS-associated_autoimmune_leukoproliferative_disorder|Rasopathy|Primary_low_grade_serous_adenocarcinoma_of_ovary|not_provided	38	0.0
1	KRAS(0.1%)	exon2,c.34_35delinsAA,p.G12N	0.000631	0.0006811	4499|4	2291|0	0.00114	14071|16	12	25398284	25398285	CC	TT	clustered_events	KRAS	NM_033360.4	2	c.34_35delinsAA	p.Gly12Asn	missense_variant				46	0.0
1	KRAS(0.1%)	exon2,c.34G>A,p.G12S	0.0007871	0.001582	6680|5	2294|2	0.00119	20911|25	12	25398285	25398285	C	T	clustered_events,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.34G>A	p.Gly12Ser	missense_variant	Pathogenic		Gastric_cancer|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|not_provided	39	0.0
	KMT2D(10.3%)	exon40,c.12337G>C,p.G4113R	0.103	0.167	30|3	6|0	0.07692	36|3	12	49426151	49426151	C	G	PASS	KMT2D	NM_003482.4	40	c.12337G>C	p.Gly4113Arg	missense_variant				42	0.0
	KMT2D(2.5%)	exon11,c.1749T>A,p.P583=	0.025	0.009187	794|25	146|3	0.07476	2203|178	12	49445717	49445717	A	T	panel_of_normals	KMT2D	NM_003482.4	11	c.1749T>A	p.Pro583=	synonymous_variant				17	0.0
	ERBB3(35.9%)	exon7,c.785C>A,p.P262H	0.359	0.036	136|76	37|0	0.35628	159|88	12	56481857	56481857	C	A	PASS	ERBB3	NM_001982.4	7	c.785C>A	p.Pro262His	missense_variant	Likely_pathogenic		Neoplasm	54	0.0
	BTG1(5.8%)	exon2,c.435C>T,p.S145=	0.058	0.077	82|6	14|0	0.05882	96|6	12	92537937	92537937	G	A	PASS	BTG1	NM_001731.3	2	c.435C>T	p.Ser145=	synonymous_variant				43	0.0
	TBX3(7.3%)	exon5,c.898C>T,p.Q300*	0.073	0.077	54|4	17|0	0.08696	63|6	12	115114259	115114259	G	A	orientation	TBX3	NM_005996.4	5	c.898C>T	p.Gln300*	stop_gained				59	0.0
-	HNF1A(9.8%)	exon4,c.872dup,p.G292fs	0.098	0.118	62|5	7|0	0.07368	88|7	12	121432117	121432117	G	GC	panel_of_normals,slippage	HNF1A	NM_000545.8	4	c.872dup	p.Gly292fs	frameshift_variant	Pathogenic		Maturity_onset_diabetes_mellitus_in_young|Clear_cell_carcinoma_of_kidney|Diabetes_mellitus_type_1|Hepatic_adenomas,_familial|Maturity-onset_diabetes_of_the_young,_type_3|Diabetes_mellitus,_insulin-dependent,_20|not_provided	33	0.0
	NCOR2(38.5%)	exon16,c.1529_1531dup,p.Q510dup	0.385	0.167	10|8	7|0	0.31034	20|9	12	124887058	124887058	G	GGCT	germline,panel_of_normals,slippage	NCOR2	NM_006312.6	16	c.1529_1531dup	p.Gln510dup	conservative_inframe_insertion	Benign		not_provided	37	0.0
-	BRCA2(1.2%)	exon23,c.9097dup,p.T3033fs	0.012	0.007324	1844|26	386|3	0.01576	3186|51	13	32954022	32954022	C	CA	panel_of_normals,slippage	BRCA2	NM_000059.4	23	c.9097dup	p.Thr3033fs	frameshift_variant	Pathogenic		Breast_carcinoma|Neoplasm_of_ovary|Hereditary_breast_and_ovarian_cancer_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial_1|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast_and/or_ovarian_cancer|not_provided	39	0.0
	PHGR1(27.7%)	exon4,c.135_200del,p.P46_P67del	0.277	0.256	128|4	23|0	0.00000	213|0	15	40648314	40648380	ACTGCGGGCCACCCCCTGGCCATGGCCCAGGGCCCTGCGGGCCACCCCCCCACCATGGTCCAGGGCC	A	multiallelic,panel_of_normals	PHGR1	NM_001145643.2	4	c.135_200del	p.Pro46_Pro67del	disruptive_inframe_deletion				47	0.0
	BLM(1.8%)	exon7,c.1544del,p.N515fs	0.018	0.02	11368|281	3554|93	0.02314	49736|1178	15	91304138	91304139	GA	G	normal_artifact,panel_of_normals,slippage	BLM	NM_000057.4	7	c.1544del	p.Asn515fs	frameshift_variant	Pathogenic		Bloom_syndrome	36	0.0
	CHD2(5.8%)	exon29,c.3734del,p.K1245fs	0.058	0.092	954|63	149|14	0.04894	1438|74	15	93540315	93540316	GA	G	multiallelic,normal_artifact,panel_of_normals,slippage	CHD2	NM_001271.4	29	c.3734del	p.Lys1245fs	frameshift_variant&splice_region_variant	Pathogenic/Likely_pathogenic		Developmental_and_epileptic_encephalopathy_94|History_of_neurodevelopmental_disorder|not_provided	29	0.0
	CHD2(3.8%)	exon33,c.4173dup,p.Q1392fs	0.038	0.033	261|9	32|0	0.02452	358|9	15	93545433	93545433	G	GA	panel_of_normals,slippage	CHD2	NM_001271.4	33	c.4173dup	p.Gln1392fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(3),Uncertain_significance(1)	CHD2-Related_Disorder|Autistic_behavior|Seizures|Developmental_and_epileptic_encephalopathy_94|Complex_neurodevelopmental_disorder|not_provided	19	0.0
	LGALS9B(43.7%)	exon1,c.17C>G,p.S6C	0.437	0.059	14|6	26|0	0.34483	19|10	17	20370767	20370767	G	C	germline,panel_of_normals	LGALS9B	NM_001042685.3	1	c.17C>G	p.Ser6Cys	missense_variant	Benign		not_specified	11	0.0
-	SMAD4(55.7%)	exon3,c.302G>A,p.W101*	0.557	0.002074	755|963	769|0	0.56254	1427|1835	18	48575108	48575108	G	A	PASS	SMAD4	NM_005359.6	3	c.302G>A	p.Trp101*	stop_gained	Pathogenic		Juvenile_polyposis/hereditary_hemorrhagic_telangiectasia_syndrome	42	0.0
	CIC(14.2%)	exon18,c.4289C>T,p.A1430V	0.142	0.091	24|3	13|0	0.08333	33|3	19	42798418	42798418	C	T	orientation	CIC	NM_015125.5	18	c.4289C>T	p.Ala1430Val	missense_variant				45	0.0
	AMER1(26.4%)	exon2,c.1891C>T,p.R631*	0.264	0.071	54|19	20|0	0.27586	63|24	X	63411276	63411276	G	A	PASS	AMER1	NM_152424.4	2	c.1891C>T	p.Arg631*	stop_gained				42	0.0
	MED12(36.8%)	exon2,c.130G>A,p.G44S	0.368	0.035	223|128	38|0	0.35056	289|156	X	70339253	70339253	G	A	PASS	MED12	NM_005120.3	2	c.130G>A	p.Gly44Ser	missense_variant	other		Uterine_leiomyoma|Angiosarcoma	47	0.0
